No adverse events were associated with GLP-1 receptor agonist therapy after shoulder surgery, indicating potential benefits for recovery.
The systematic review included multiple studies, and findings suggest that GLP-1 receptor agonists may be safe options for patients undergoing surgery.
Assessment using systematic review and meta-analysis confirmed the absence of adverse events after shoulder surgeries with GLP-1 receptor agonists.
These findings support the use of GLP-1 receptor agonists in clinical settings, but further studies are necessary to confirm safety across diverse patient populations.